CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 161649-161923 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1276","span":{"begin":0,"end":274},"obj":"Sentence"},{"id":"T76606","span":{"begin":0,"end":274},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Major examples of HAART-related toxicity include mitochondrial damage and lipoatrophy associated with the use of nucleos(t)ide reverse transcriptase inhibitors (NRTIs), and fat accumulation, dyslipidaemia and insulin resistance associated with the protease inhibitors (PIs)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T140","span":{"begin":0,"end":274},"obj":"Sentence"}],"text":"Major examples of HAART-related toxicity include mitochondrial damage and lipoatrophy associated with the use of nucleos(t)ide reverse transcriptase inhibitors (NRTIs), and fat accumulation, dyslipidaemia and insulin resistance associated with the protease inhibitors (PIs)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T134","span":{"begin":74,"end":85},"obj":"Phenotype"},{"id":"T135","span":{"begin":209,"end":227},"obj":"Phenotype"}],"attributes":[{"id":"A134","pred":"hp_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/HP_0100578"},{"id":"A135","pred":"hp_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/HP_0000855"}],"text":"Major examples of HAART-related toxicity include mitochondrial damage and lipoatrophy associated with the use of nucleos(t)ide reverse transcriptase inhibitors (NRTIs), and fat accumulation, dyslipidaemia and insulin resistance associated with the protease inhibitors (PIs)."}